Home›Research›Compare›AOD-9604 vs Retatrutide
Peptide ComparisonAOD-9604 vs Retatrutide
AOD-9604
Advanced Obesity Drug 9604
Half-life: 30–60 minutes
197 providers listed
Retatrutide
GLP-3
Half-life: ~6 days
96 providers listed
AOD-9604 and Retatrutide target different goals — AOD-9604 for selective fat tissue lipolysis via GH C-terminal fragment mechanism, Retatrutide for profound weight loss. They're compared here for reference, not as direct substitutes.
AOD-9604
Half-life
30–60 minutes
Retatrutide
Half-life
~6 days
AOD-9604 and Retatrutide target different goals — AOD-9604 for GH / IGF Axis, Retatrutide for Metabolic. They're compared here for reference; there isn't a single “better” choice between them.
AOD-9604
Retatrutide
AOD-9604
Retatrutide
Benefits and Harms of Pharmacologic Treatments in Adults With Overweight or Obesity: A Living Systematic Revi…
Retatrutide And Lipid And Metabolite Profiles In Participants With Obesity With Or Without Type 2 Diabetes.
Design of the TRIUMPH phase 3 clinical trial programme for retatrutide in obesity and cardiometabolic disease
Triple-hormone-receptor agonist retatrutide for obesity — a phase 2 trial
+6 more
About AOD-9604
AOD-9604 stimulates lipolysis and inhibits lipogenesis through mechanisms believed to be independent of the insulin-like growth factor pathway. It appears to mimic the fat-metabolising action of growth hormone without triggering the proliferative effects associated with full GH or GH-releasing peptides. Oral bioavailability has been observed in some formulations, making it of interest for non-injectable protocols.
About Retatrutide
Triple GIP/GLP-1/glucagon receptor agonist; targets three pathways for synergistic fat reduction
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
AOD-9604
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Retatrutide
Class-based (investigational)
AOD-9604
Retatrutide
Where to source these peptides
AOD-9604
197 listed
Browse directory →
Providers offeringRetatrutide
96 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
Related Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). AOD-9604 vs Retatrutide — Per-mg Price Comparison. Retrieved September 11, 2026, from https://peptidebase.io/peptides/compare/aod-9604/retatrutide